What is Argos?
Argos Corporation operates as a key player in the custom manufacturing of specialized polymer products. With a strong focus on serving the medical, pharmaceutical, and industrial markets, the company leverages its ISO 9001 and ISO 13485 certifications to guarantee high standards of quality and compliance. Their product portfolio includes a diverse range of extrusion tubing and filaments, with a notable capability for developing bespoke solutions tailored to precise client specifications. Argos is recognized for its commitment to delivering high-quality, competitively priced offerings that adapt to the dynamic needs of its clientele.
How much funding has Argos raised?
Argos has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Argos?
The substantial capital infusion, particularly the recent strategic investment, positions Argos for accelerated development and market penetration. As a company operating within a large-scale, late-stage funding context, this backing is likely to support significant operational scaling, research and development initiatives, and potentially strategic acquisitions. Argos's focus on certified, high-quality thermoplastic solutions for critical industries suggests a strategic direction aimed at solidifying its leadership and expanding its technological capabilities. Future growth may involve enhancing production capacity, exploring new material science applications, and broadening its global reach.
See full Argos company page
